Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial.
Chia JWK, Segelov E, Deng Y, Ho GF, Wang W, Han S, Sharma A, Ding K, Chen G, Jeffery MG, Tham CK, Ahn JB, Nott L, Zielinski R, Chao TY, van Hagen T, Wei PL, Day F, Mehta S, Yau T, Peng J, Hayes TM, Li Y, Gandhi M, Foo EMJ, Rahman N, Rothwell P, Ali R, Simes J, Toh HC.
Chia JWK, et al. Among authors: han s.
Lancet Gastroenterol Hepatol. 2025 Jan 14:S2468-1253(24)00387-X. doi: 10.1016/S2468-1253(24)00387-X. Online ahead of print.
Lancet Gastroenterol Hepatol. 2025.
PMID: 39824200